Skip to main content

Guanfacine

NDC 70436-042 · Slate Run Pharmaceuticals, LLC

Generic nameguanfacine

Dosage formTABLET, EXTENDED RELEASE

RouteORAL

Active ingredient(s)GUANFACINE HYDROCHLORIDE

Strength4 mg/1

Pharmacologic classAdrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]

Marketing categoryANDA

Packages

70436-042-01 — 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (70436-042-01)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

63629-8161 — Guanfacine, 63629-8203 — Guanfacine, 65162-711 — Guanfacine, 65162-713 — Guanfacine, 67046-1433 — Guanfacine, 67046-1655 — Guanfacine, 68094-065 — Guanfacine, 70436-039 — guanfacine, 70436-040 — guanfacine, 70436-041 — guanfacine, 70518-4266 — guanfacine, 70518-4333 — Guanfacine, 70518-4488 — Guanfacine, 70518-4539 — Guanfacine, 70518-4564 — Gaunfacine, 70518-4675 — Guanfacine, 70700-301 — Guanfacine Hydrochloride, 70700-302 — Guanfacine Hydrochloride, 71335-2379 — GUANFACINE, 71335-2852 — guanfacine, +83 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels